Veriheal

JUNE 24, 2022

Thailand left its war on drugs in the past, the Texas GOP platform raised some questions, and a new study revealed how cannabis legalization affects road safety. Thailand’s Cannabis Turn-Around. You may even find yourself sampling some delicious cannabis-infused curry along the way. Let us know in the comments!

Safety 98

Safety Policy History Cannabis 98

Cannabis Law Report

JULY 29, 2021

When it comes to buying a cannabis enthusiast’s home, the resale value research is less clear, though 30% of realtors say they have struggled to sell a house where cannabis was grown. Legal cannabis raises home value. There’s been a lot of chatter surrounding cannabis and the real estate market.

Data 116

Data Legalization Education Programs 116

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. The primary endpoint of our Phase 1 clinical trial was to test and demonstrate safety and tolerability.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Medicinal Genomics

JULY 14, 2022

Several articles have been published recently describing the challenges of microbial testing on cannabis and hemp. We believe a better way to ensure consumer safety is to perform species-specific tests that target known pathogenic organisms, such as A. One thing that all these articles have in common is total count tests. fumigatus, A.

Safety 92

Safety Research and Development Concentrates Food 92

Cannabis Law Report

AUGUST 19, 2022

La Jolla, CA: The establishment of licensed cannabis retailers is not independently associated with an increase in traffic crashes, according to data published in the journal Health Economics. Full text of the study, “Does expanding access to cannabis affect traffic crashes?

Safety 52

Safety Retail Data Access 52

Cannabis Law Report

DECEMBER 4, 2019

The North American College of Pharmaceutical Technology (NACPT) is conducting a pilot series of professionals in medical cannabis workshops, and we spent a day learning and discussing food safety, regulatory tech, processes and systems. This bean-to-bar cannabis infused chocolate (above) is part of Canopy Growth’s 2.0

Safety 75

Safety Supply Chain Environment Food 75

Cannabis Law Report

MAY 26, 2022

The data tool can be found on the DCC website here: [link]. And even more cities and counties – 62 percent – prohibit the licensing of any form of cannabis retail. — CA Department of Cannabis Control (@CAcannabisdept) May 26, 2022. SACRAMENTO, Calif.–( Tweet this. CAcannabis #Map.

Data 52

Data Access Business Retail 52

Cannabis Law Report

MARCH 21, 2020

Law Enforcement Related to Cannabis. The Cannabis Act , which sets out the legal framework for controlling the production, distribution, sale and possession of cannabis across Canada, came into force on October 17, 2018. Background. Current Status. PS is working with the PTs and other key stakeholders (e.g.,

Safety 88

Safety Research and Development Data Cannabis 88

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. – Phase 2 Trial Underway. AIkido Pharma Inc.:

Data 100

Data Research and Development Clinical Trials Therapy 100

Cannabis Law Report

MAY 18, 2022

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The study abstract is available here. The methods for both phases were the same.

Safety 52

Safety Hemp Research and Development Data 52

NORML

FEBRUARY 11, 2020

The enactment of state-specific medical cannabis access laws is associated with a decline in workers’ compensation claims, according to data published in the journal Health Economics. Authors reported that legal cannabis access was associated with a nearly seven percent decline in workers’ compensation claims.

Access 288

Access Safety Data Marijuana 288

Cannabis Law Report

MAY 31, 2023

General Counsel Jonathan Miller Raises Concerns Regarding FDA’s Stance on CBD Regulation WASHINGTON D.C. — On the heels of last week’s U.S. Food and Drug Administration (FDA) webinar for hemp industry stakeholders, “A New Way Forward for Cannabidiol and Other Hemp Products,” U.S.

Safety 52

Safety Data CBD Hemp 52

SpeedWeed

AUGUST 25, 2021

Cannabis consumers who are aspiring to receive a commercial driver’s license (CDL) to drive trucks and other commercial vehicles should seriously consider the pros and cons of their career outlook. Data shows that commercial drivers are consuming cannabis more than any other drug, even if it can ruin their career.

Data 52

Data CBD Cannabis Safety 52

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. The search included studies through 11-May-2020. Eight studies were included, all of which are randomized controlled trials.

Safety 52

Safety Cannabinoids Events Data 52

The Blunt Truth

JULY 18, 2022

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green.

DEA 98

DEA Data Decriminalization Legalization 98

Veriheal

AUGUST 24, 2023

Activities in cannabis farms are gradually picking up after the Washington D.C. authorities shut down cannabis facilities in April due to unacceptable levels of Dichlorodiphenyldichloroethylene (DDT)-related chemicals detected in cannabis harvest. There just isn’t experimental data available,” Simpson said.

Data 96

Data Safety Extraction Cannabis 96

Veriheal

JULY 25, 2023

are increasingly relaxing their cannabis laws, it’s no surprise that the drug’s consumption has grown , especially among American workers. Also, the medical use of cannabis is legal in more than 36 states. But has this led to more positive cannabis drug tests? But has this led to more positive cannabis drug tests?

Safety 90

Safety Data Recreational Marijuana 90

SpeedWeed

MARCH 21, 2021

As is the case in the United States, Europe lacks sufficiently reliable scientific data to support the safety of products infused with full spectrum hemp extract. In January 2019, the European Union (EU) reclassified extracts of cannabis sativa L. Read the entire article at The Fresh Toast. View original article.

Safety 52

Safety Hemp Extraction Sativa 52

Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 243

Cannabinoids Data Safety Patients 243

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

NORML

FEBRUARY 19, 2020

Jobs in the state-licensed cannabis industry rose 15 percent during the past 12 months, and the industry now employs over 243,000 full-time workers, according to data compiled by Leafly.com. According to its 2020 report , the regulated cannabis industry added 33,700 new jobs over the past year.

Legalization 343

Legalization Marijuana Data Safety 343

NORML

JUNE 18, 2019

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.

Patients 279

Patients Therapy Data Safety 279

Cannabis Law Report

NOVEMBER 2, 2021

NORML is pleased to announce that its newly updated and revised publication, Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021 , is now available for download on the Kindle app. Proceeds from the purchase of the new book directly fund NORML’s cannabis advocacy efforts.

Safety 52

Safety Patients Chronic Pain Advocacy 52

NORML

MAY 19, 2020

The enactment of adult-use cannabis legalization laws in Colorado and Washington is associated with increased tourism in both states, according to data published in the Journal of Regional Analysis & Policy. Both states experienced their highest jumps in tourism following the advent of retail cannabis sales.

Legalization 335

Legalization Marijuana Data Policy 335

Cannabis Law Report

FEBRUARY 24, 2022

This summary includes results for cannabis inspections from April 1, 2019 to March 31, 2020. Conducted to monitor and verify compliance of the licence holder with the requirements of the Cannabis Act and its regulations. Conducted to assess compliance with promotion requirements as defined in the Cannabis Act and its regulations.

Compliance 52

Compliance Compliance Data Safety 52

Cannabis Law Report

JULY 21, 2022

Patient safety concerns uncovered during an ongoing federal review have led to the suspension of one of two clinical trials for MDMA-assisted psychotherapy currently underway in Canada. A spokesperson told CBC in an email that the study was put on hold “due to concerns for participant safety.” CBC Canada.

Safety 52

Safety Patients Clinical Trials Data 52

Cannabis Cheri

MARCH 25, 2021

The FDA, which requested science-based data to help inform regulatory decisions for hemp-derived CBD products, has been informed by ValidCare investigators about the positive results of the study. Once completed, safety results of this study will be shared with participating brands and FDA. Read more about the study here.

CBD 235

CBD Data Safety Tincture 235

NORML

OCTOBER 8, 2019

The enactment of statewide legislation permitting adult cannabis possession and sales is not associated with any significant or long-term uptick in criminal activity, according to data published in the journal Justice Quarterly. Additional information is available from the NORML fact-sheet , ‘Marijuana Regulation and Crime Rates.’

Legalization 215

Legalization Data Safety Retail 215

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

NORML

MARCH 5, 2019

The state-licensed cannabis industry gained over 64,000 new employees in 2018, and now employs over 200,000 full-time workers, according to data compiled by Whitney Economics and the online content provider Leafly.com. This total increased to 296,000 jobs when ancillary employers are included. The full report is available online here.

Legalization 275

Legalization Marijuana Data Safety 275

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

Clinical Trials 244

Clinical Trials Chronic Pain Cannabinoids Patients 244

Veriheal

NOVEMBER 21, 2023

Veriheal remains dedicated to supporting the next generation of pioneers through its Innovation in Cannabis Scholarship. This year, we are proud to continue our investment in the next generation of cannabis industry leaders. Their one-of-a-kind innovations and solutions are invaluable to the future of cannabis.

Research and Development 106

Research and Development Consumption Education Data 106

Cannabis Law Report

JULY 20, 2022

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JULY 18, 2022

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green.

DEA 52

DEA Data Decriminalization Legalization 52

NORML

AUGUST 29, 2019

Remarks made today by the United States Surgeon General highlighting “the importance of protecting our nation from the health risks of marijuana use in adolescents and during pregnancy” fail to acknowledge the role that a regulated market can play in mitigating the use of cannabis by potentially high-risk populations.

Education 221

Education Data Retail Environment 221

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52